HopeStage
Back to all studies
CompletedNCT03005769

Predictors of Staying on Monthly Aripiprazole in Italian Clinical Practice

About this titleRead the official source — NCT03005769
Observational studyAges 18+ItalySchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Ancona and 19 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: December 2016
Recruitment status
Completed
Enrollment listed in the registry
262
Sponsor
Otsuka Pharmaceutical Europe Ltd
Sponsor type
Pharmaceutical company
Study type
Observational
Intervention type
Interview / survey / observational
Locations
Italy
Age range
Over 18 Years
Official registry ID
NCT03005769
Official title
Show the full official title

Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in the Italian Clinical Practice: a Retrospective Cohort, Observational Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Ancona · Brescia · Cagliari

16 more locations
  • Catania
  • Catanzaro
  • Florence
  • Genzano di Roma
  • Giulianova
  • Lecce
  • Milan
  • Monza
  • Orbassano
  • Padova
  • Palermo
  • Perugia
  • Pomezia
  • Pontecagnano
  • Siena
  • Treviso

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Otsuka Pharmaceutical Europe Ltd, a pharmaceutical company.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies